Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
企業コードZYXI
会社名Zynex Inc
上場日Nov 27, 2002
最高経営責任者「CEO」- -
従業員数1000
証券種類Ordinary Share
決算期末Nov 27
本社所在地9655 Maroon Circle
都市ENGLEWOOD
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号80112
電話番号18004956670
ウェブサイトhttps://www.zynex.com/
企業コードZYXI
上場日Nov 27, 2002
最高経営責任者「CEO」- -
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし